Neuroprotective effects of the gliopeptide ODN in an in vivo model of Parkinson's disease.

about

Neuroprotective effects of the gliopeptide ODN in an in vivo model of Parkinson's disease.

Item

http://www.wikidata.org/entity/Q47267653

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Neuroprotective effects of the ...... model of Parkinson's disease.

@en

Neuroprotective effects of the ...... model of Parkinson's disease.

@nl

type

Item

label

Neuroprotective effects of the ...... model of Parkinson's disease.

@en

Neuroprotective effects of the ...... model of Parkinson's disease.

@nl

prefLabel

Neuroprotective effects of the ...... model of Parkinson's disease.

@en

Neuroprotective effects of the ...... model of Parkinson's disease.

@nl

P1476

Neuroprotective effects of the ...... model of Parkinson's disease.

@en

P2093

David Vaudry

http://www.w3.org/2001/XMLSchema#string

Hubert Vaudry

http://www.w3.org/2001/XMLSchema#string

Ikram Ghouili

http://www.w3.org/2001/XMLSchema#string

Jean-Claude do Rego

http://www.w3.org/2001/XMLSchema#string

Jean-Luc do Rego

http://www.w3.org/2001/XMLSchema#string

Julien Chuquet

http://www.w3.org/2001/XMLSchema#string

Mansour Hmiden

http://www.w3.org/2001/XMLSchema#string

Marie-Christine Tonon

http://www.w3.org/2001/XMLSchema#string

Mohamed Amri

http://www.w3.org/2001/XMLSchema#string

Olfa Masmoudi-Kouki

http://www.w3.org/2001/XMLSchema#string

P2860

Molecular cloning of the gene for the yeast homolog (ACB) of diazepam binding inhibitor/endozepine/acyl-CoA-binding protein

Study of an octadecaneuropeptide derived from diazepam binding inhibitor (DBI): biological activity and presence in rat brain

Epidemiology of Parkinson's disease

The octadecaneuropeptide [diazepam-binding inhibitor (33-50)] exerts potent anorexigenic effects in rodents.

Immunocytochemical localization of the endogenous benzodiazepine ligand octadecaneuropeptide (ODN) in the rat brain.

The octadecaneuropeptide ODN protects astrocytes against hydrogen peroxide-induced apoptosis via a PKA/MAPK-dependent mechanism.

Disruption of the acyl-CoA-binding protein gene delays hepatic adaptation to metabolic changes at weaning

Protocol for the MPTP mouse model of Parkinson's disease.

Increased plasma levels of endozepines, endogenous ligands of benzodiazepine receptors, during systemic inflammation: a prospective observational study

Pain perception in acute model mice of Parkinson's disease induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)

P2888

s00018-017-2727-2

P304

2075-2091

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00018-017-2727-2

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-12-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29264673

http://www.w3.org/2001/XMLSchema#string

P921

Parkinson's disease